Atlas Trials

Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy

Clinical trial NCT05448066 · UNKNOWN

Trial details

NCT number
NCT05448066
Sponsor
Universidade do Porto
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
AsthmaRhinitis, Allergic
Start date
2022-07-30
Primary completion
2026-04-30
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.